Literature DB >> 8725568

New challenges to the therapy of systemic fungal infections.

G Medoff1.   

Abstract

In summary, the recent increase in frequency of systemic fungal infections has stimulated the development of new antifungal agents which are easier to use and which have decreased toxicity. This has resulted in increase in use, and along with this, the appearance of fungi resistant to antifungal agents. The medical community will have to come to terms with this newly emerging problem.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8725568      PMCID： PMC2376576     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


  21 in total

1.  Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting.

Authors:  S H Salzman; R L Smith; C P Aranda
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

Review 2.  Antifungal agents useful in therapy of systemic fungal infections.

Authors:  G Medoff; J Brajtburg; G S Kobayashi; J Bolard
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

3.  Protective effects of amphotericin B against spontaneous and transplantable murine tumors.

Authors:  F Valeriote; R Lynch; G Medoff; B V Kumar
Journal:  J Natl Cancer Inst       Date:  1976-03       Impact factor: 13.506

4.  Cryptococcosis in the acquired immunodeficiency syndrome.

Authors:  J A Kovacs; A A Kovacs; M Polis; W C Wright; V J Gill; C U Tuazon; E P Gelmann; H C Lane; R Longfield; G Overturf
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells.

Authors:  J Brajtburg; S Elberg; J Medoff; G S Kobayashi; D Schlessinger; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

6.  Amphotericin B-induced oxidative damage and killing of Candida albicans.

Authors:  M L Sokol-Anderson; J Brajtburg; G Medoff
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

7.  Amphotericin B-resistant yeast infection in severely immunocompromised patients.

Authors:  W G Powderly; G S Kobayashi; G P Herzig; G Medoff
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

8.  Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

Authors:  W G Merz
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

9.  Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.

Authors:  S L Kelly; D C Lamb; A J Corran; B C Baldwin; D E Kelly
Journal:  Biochem Biophys Res Commun       Date:  1995-02-27       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.